Physician profile
Felicia L Johnson
NPI 1801986393
$2,310.46
in general payments reported to CMS, 2019-2025
25 companies · $474 in 2025
The $474 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $464 · 2020: $59.64 · 2021: $266 · 2022: $372 · 2023: $182 · 2024: $493 · 2025: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $938 · Education: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $938.13 |
| Education | $210.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $370.43 | 2019-2025 | Dupixent, Libtayo |
| Stryker Corporation | $356.38 | 2021-2025 | Scopis Ent |
| Intersect Ent, INC. | $199.32 | 2019-2021 | |
| Genzyme Corporation | $191.68 | 2022-2025 | |
| Boston Scientific Corporation | $148.75 | 2019 | |
| Glaxosmithkline, LLC. | $142.64 | 2022-2025 | Nucala |
| Sanofi-Aventis U.S. LLC | $129.94 | 2024-2025 | |
| Acclarent, INC | $110.76 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $86.87 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.09 | 2022-2024 | Jardiance |
| Inspire Medical Systems, INC. | $77.20 | 2023-2025 | Inspire |
| Medtronic, INC. | $77.19 | 2021-2025 | Stealthstation S8 Platform, Ligasure |
| Astellas Pharma US INC | $77.00 | 2022 | |
| Ethicon US, LLC | $38.48 | 2019 | |
| Olympus America INC. | $30.18 | 2025 | Olympus, Single-Use Flexible Video Bronchoscope, Rhino-Laryngo Videoscope |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $27.04 | 2024 | Grafix |
| Biowound Solutions, INC. | $23.93 | 2025 | Bio-Connekt |
| Abbott Laboratories | $21.27 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $21.09 | 2025 | Opsynvi, Opsumit, Uptravi |
| Integra Lifesciences Corporation | $19.69 | 2024 | Microfrance, Integra Duo, Codman Isocool Aht |
| Aerin Medical INC. | $17.49 | 2020 | |
| Spark Therapeutics, INC. | $16.95 | 2019 | |
| Philips North America LLC | $15.43 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $13.56 | 2023 | Seglentis |
| Kaleo, INC. | $11.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felicia Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.